Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Clin Cancer Res. 2010 Oct 26;16(21):5277–5287. doi: 10.1158/1078-0432.CCR-10-0791

Table 2. Clinical (A.) and laboratory (B.) toxicity in patients treated with Ad5-Δ24-RGD by category and grade.

A.
Body System Toxicity Grades (NCI CTC V.3) Total Occurrences
1 2 3 4
Gastrointestinal 61 34 6 0 101
Constitutional 18 6 0 0 24
Pain 10 8 1 0 19
Neurology 4 4 0 0 8
Infection 1 6 0 0 7
Dermatology/Skin 0 4 1 0 5
Cardiac General 2 2 0 0 4
Lymphatics 3 1 0 0 4
Musculoskeletal 3 1 0 0 4
Allergy/Immunology 3 0 0 0 3
Syndromes 0 2 0 0 2
Respiratory 0 0 1 0 1
Renal/Genitourinary 0 1 0 0 1
Blood/Bone Marrow 1 0 0 0 1
Cardiac Arrhythmia 1 0 0 0 1
B.
Lab Tests Toxicity Grades (NCI CTC V.3) Total Occurrences
1 2 3 4
Hemoglobin 42 7 0 0 49
Hematocrit 34 12 0 0 46
Glucose 24 5 0 0 29
Potassium 11 1 1 0 14
LDH 8 2 0 0 10
Creatinine 6 0 0 0 6
GGT 4 1 0 0 5
WBC 5 0 0 0 5
Sodium 2 3 0 0 5
Alkaline Phosphatate 5 0 0 0 5
Calcium 2 2 0 0 4
Phosphorous 2 2 0 0 4
Bicarbonate 4 0 0 0 4
Chloride 0 2 0 0 2
BUN 2 0 0 0 2
Total Bilirubin 1 0 0 0 1
Uric Acid 0 0 0 0 0
Platelet 0 0 0 0 0